Efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 variant of concern 202012/01 (B.1.1.7): an exploratory analysis of a randomised controlled trial. (2021)
Attributed to:
Respiratory infections
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/s0140-6736(21)00628-0
PubMed Identifier: 33798499
Publication URI: http://europepmc.org/abstract/MED/33798499
Type: Journal Article/Review
Volume: 397
Parent Publication: Lancet (London, England)
Issue: 10282
ISSN: 0140-6736